Glenmark infringed Bayer’s Finacea patent, says Federal Circuit

18-05-2016

Glenmark infringed Bayer’s Finacea patent, says Federal Circuit

Lukassek / Shutterstock.com

The US Court of Appeals for the Federal Circuit ruled that Glenmark Pharmaceuticals infringed a Bayer Healthcare patent for the rosacea treatment Finacea.


Glenmark, Bayer, patent, Finacea, FDA, ANDA

LSIPR